Equity Details
Price & Market Data
Price: $5.00
Daily Change: -$0.52 / 10.40%
Daily Range: $4.77 - $5.37
Market Cap: $865,824
Daily Volume: 169,705
Performance Metrics
1 Week: -13.83%
1 Month: -84.88%
3 Months: -87.78%
6 Months: -98.21%
1 Year: -98.69%
YTD: -96.73%
About Aspire Biopharma Holdings, Inc. (ASBP)
Comprehensive financial data on Aspire Biopharma Holdings, Inc. (ASBP). Trading at 5.00, it has a daily change of -$0.52 / 10.40%. Market cap: 865,824. Review its performance from the last week to the last year.
Details
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.